Late presentation of CardioSEAL PFO closure device fracture and thrombus formation three years after device implantation

Journal of Invasive Cardiology

Volumn 20, Issue 8, 2008, Pages

  Narayan, Vidya ^a,c   Puri, Poonam ^a   Mehra, Anilkumar O ^a,b  

^a LAC USC MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Division of Cardiology Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ADULT; APHASIA; ARM FRACTURE; ARTICLE; BRAIN INFARCTION; CASE REPORT; CEREBROVASCULAR ACCIDENT; DEVICE MALPOSITION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM THROMBOSIS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMPLANTATION; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT FORAMEN OVALE; PHYSICAL EXAMINATION; THORAX RADIOGRAPHY; THROMBOGENESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; WEAKNESS;

ADULT; DEVICE REMOVAL; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HEART DISEASES; HUMANS; PROSTHESES AND IMPLANTS; PROSTHESIS FAILURE; PROSTHESIS IMPLANTATION; REOPERATION; STROKE; THROMBOSIS; TIME FACTORS;

EID: 48749094156     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chessa M, Carminati M, Butera G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-1065.
2. Maissel WH, Laskey WK. Patent foramen closure devices moving beyond equipoise. JAMA 2005;294:366-369.
3. Bridges ND, Helenbrand W, Latson L, et al. Transcatheter occlusion of patent foramen ovale aft er presumed paradoxical embolism. Circulation 1992;86:1902-1908.
4. Latson L. The CardioSEAL device: History, techniques, results. J Intervent Cardiol 1998;11:501-505.
5. Prieto LR, Foreman CK, Cheatham JP, Latson L. Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard clamshell septal umbrella. Am J Cardiol 1996;78:1310-1312.
6. www.fda.gov/cdrh/pdf/P000049b.doc
7. Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J Am Coll Cardiol 2004;43:302-309.
8. Anzai H, Child J, Natterson B, et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interat rial closure devices. Am J Cardiol 2004;93:426-431.
9. Braun M, Fassbender D, Schoen S, et al. Transcatheter closure of patients with patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
10. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow up results of three different device occluder systems. Eur Heart J 2004;24:424-430.
11. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale (PFO) in patients with paradoxical embolism: Long term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
12. Martìn F, Sànchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Circulation 2002;106:1121-1126.